Future Directions for Pharmacogenetics

Michael W. Jann, Y. W.Francis Lam

Research output: Contribution to journalArticlepeer-review


The discipline of pharmacogenetics will continue to expand as scientific and clinical investigations increase our understanding of genetic variabilities in drug metabolism and response. These research efforts will include determination of molecular mechanisms for the different polymorphisms and evaluation of their clinical significance. The availability of molecular methodologies such as restriction fragment length polymorphisms analysis, polymerase chain reaction, and expression of cDNAs in cell cultures will further the investigative work in detection of normal and mutant alleles, identification of new substrates for different polymorphic metabolizing enzymes, and evaluation of mechanisms of individual susceptibility to biological disorders. Other areas such as the role of pharmacogenetics in drug development and regulatory control, in evaluation of potential drug-drug interactions, ethnic variation in polymorphic metabolism, and response, also need to be evaluated.

Original languageEnglish (US)
Pages (from-to)44-46
Number of pages3
JournalJournal of Pharmacy Practice
Issue number1
StatePublished - Feb 1993

ASJC Scopus subject areas

  • Pharmacology (medical)


Dive into the research topics of 'Future Directions for Pharmacogenetics'. Together they form a unique fingerprint.

Cite this